Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2013 Aug 6;3(2):e22.
doi: 10.4081/cp.2013.e22. eCollection 2013 Aug 2.

Rhabdomyolysis as a presenting manifestation of very long-chain acyl-coenzyme a dehydrogenase deficiency

Affiliations
Case Reports

Rhabdomyolysis as a presenting manifestation of very long-chain acyl-coenzyme a dehydrogenase deficiency

Sara Freitas Oliveira et al. Clin Pract. .

Abstract

Very long-chain acyl-coenzyme A dehydrogenase (VLCAD) deficiency (MIM 201475) is a rare inherited disorder with three forms of clinical presentation: a severe early-onset form; an intermediate form with childhood onset; and an adult-onset form, of mild severity. During adolescence and adulthood, exercise intolerance, myalgia and recurrent episodes of rhabdomyolysis are the main clinical features. The authors present a case of a 13-year old female, with severe myalgia and dark urine after prolonged exercise. Analytical evaluation showed marked elevation plasma creatine kinase and myoglobin. The increased levels of tetradecenoyl carnitine in patient's dried blood spot suggested a VLCAD deficiency, which was confirmed by molecular study. Family history is remarkable for first grade consanguinity of parents and a 19-year old brother with records of repeated similar episodes after moderate intensity physical efforts which was subsequently also diagnosed with VLCAD deficiency. This is one of the first cases of late-onset of disease diagnosed in Portugal.

Keywords: metabolic myopathy; rhabdomyolysis; very long-chain acylcoenzyme A dehydrogenase deficiency.

PubMed Disclaimer

Conflict of interest statement

Conflict of interests: the authors declare no potential conflict of interests.

Similar articles

Cited by

References

    1. Guis S, Mattei JP, Cozzone PJ, Bendahan D. Pathophysiology and clinical presentations of rhabdomyolysis. Joint Bone Spine 2005;72:382-91 - PubMed
    1. Warren JD, Blumbergs PC, Thompson PD. Rhabdomyolysis: a review. Muscle Nerve 2002;25:332-47 - PubMed
    1. Vanholder R, Sever MS, Erek E, Lameire N. Rhabdomyolysis. J Am Soc Nephrol 2000; 11:1553-61 - PubMed
    1. Lindner M, Hoffmann GF, Matern D. Newborn screening for disorders of fattyacid oxidation: experience and recommendations from an expert meeting. J Inherit Metab Dis 2010;33:521-6 - PubMed
    1. Izai K, Uchida Y, Orii T, et al. Novel fatty acid beta-oxidation enzymes in rat liver mitochondria.I. Purification and properties of very-long-chain acyl-coenzyme A dehydrogenase. J Biol Chem 1992;267:1027-33 - PubMed

Publication types

LinkOut - more resources